应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
ACGN Aceragen, Inc.
休市中 12-27 16:00:00 EST
0.3800
+0.0000
0.00%
最高
0.3800
最低
0.3800
成交量
0.00
今开
0.3800
昨收
0.3800
日振幅
0.00%
总市值
319.97万
流通市值
131.49万
总股本
842.03万
成交额
0.00
换手率
0.00%
流通股本
346.03万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
资讯
新帖
简况
普华永道:预计中国奢侈品市场2030年将跃居全球首位
智通财经 · 11-09
普华永道:预计中国奢侈品市场2030年将跃居全球首位
加载更多
公司概况
公司名称:
Aceragen, Inc.
所属市场:
NASDAQ
上市日期:
--
主营业务:
Aceragen, Inc.在特拉华州注册成立。Aceragen是一家临床阶段的生物制药公司,致力于改变患有罕见肺病和风湿病的人的护理。他们的投资组合包括基于成熟生物学原理的后期项目,他们正在开发这些项目,使之成为能够解决患有罕见疾病的个人未满足的医疗需求的创新疗法。
发行价格:
--
{"stockData":{"symbol":"ACGN","market":"US","secType":"STK","nameCN":"Aceragen, Inc.","latestPrice":0.38,"timestamp":1735333200000,"preClose":0.38,"halted":0,"volume":0,"delay":0,"floatShares":3460307,"shares":8420276,"eps":-9.471364,"marketStatus":"休市中","change":0,"latestTime":"12-27 16:00:00 EST","open":0.38,"high":0.38,"low":0.38,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-9.471364,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1735549200000},"marketStatusCode":7,"adr":0,"listingDate":822459600000,"exchange":"NASDAQ","adjPreClose":0.38,"volumeRatio":0},"requestUrl":"/m/hq/s/ACGN","defaultTab":"news","newsList":[{"id":"2482260264","title":"普华永道:预计中国奢侈品市场2030年将跃居全球首位","url":"https://stock-news.laohu8.com/highlight/detail?id=2482260264","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482260264?lang=zh_cn&edition=full","pubTime":"2024-11-09 22:25","pubTimestamp":1731162338,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,11月9日,普华永道发布《消费者之声调研》中国报告称,2024年前三季中国零售市场稳健增长,GDP增幅4.8%,零售额增3.3%。中国奢侈品市场潜力巨大,预计2030年将跃居全球首位。消费习惯上,中国消费者对可持续发展表现出兴趣全球及中国受访者普遍认为高质量产品和服务是建立品牌信任的关键。中国零售商和品牌需同时应对严格监管和消费者期望的双重压力。中国数字化进程加速对国内消费者的购买体验产生了显著影响。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1208911.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4139","ACGN"],"gpt_icon":0}],"profile":{"websiteUrl":"http://aceragen.com","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":0},{"period":"3month","weight":0},{"period":"6month","weight":0},{"period":"1year","weight":0},{"period":"ytd","weight":0}],"compareEarnings":[{"period":"1week","weight":0.0065},{"period":"1month","weight":-0.0064},{"period":"3month","weight":0.0412},{"period":"6month","weight":0.0933},{"period":"1year","weight":0.2482},{"period":"ytd","weight":0.2518}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Aceragen, Inc.在特拉华州注册成立。Aceragen是一家临床阶段的生物制药公司,致力于改变患有罕见肺病和风湿病的人的护理。他们的投资组合包括基于成熟生物学原理的后期项目,他们正在开发这些项目,使之成为能够解决患有罕见疾病的个人未满足的医疗需求的创新疗法。","yearOnYearQuotes":[{"month":1,"riseRate":0.333333,"avgChangeRate":-0.021166},{"month":2,"riseRate":0.333333,"avgChangeRate":-0.002341},{"month":3,"riseRate":0.444444,"avgChangeRate":-0.044047},{"month":4,"riseRate":0.333333,"avgChangeRate":-0.003205},{"month":5,"riseRate":0.277778,"avgChangeRate":-0.013613},{"month":6,"riseRate":0.388889,"avgChangeRate":-0.046645},{"month":7,"riseRate":0.421053,"avgChangeRate":-0.020549},{"month":8,"riseRate":0.631579,"avgChangeRate":0.100587},{"month":9,"riseRate":0.368421,"avgChangeRate":-0.01736},{"month":10,"riseRate":0.315789,"avgChangeRate":-0.054216},{"month":11,"riseRate":0.473684,"avgChangeRate":0.02938},{"month":12,"riseRate":0.526316,"avgChangeRate":0.049539}],"exchange":"NASDAQ","name":"Aceragen, Inc.","nameEN":"Aceragen, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.4","shortVersion":"4.29.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Aceragen, Inc.(ACGN)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Aceragen, Inc.(ACGN)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Aceragen, Inc.,ACGN,Aceragen, Inc.股票,Aceragen, Inc.股票老虎,Aceragen, Inc.股票老虎国际,Aceragen, Inc.行情,Aceragen, Inc.股票行情,Aceragen, Inc.股价,Aceragen, Inc.股市,Aceragen, Inc.股票价格,Aceragen, Inc.股票交易,Aceragen, Inc.股票购买,Aceragen, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Aceragen, Inc.(ACGN)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Aceragen, Inc.(ACGN)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}